^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    BL-M07D1

    i
    Other names: BL-M07D1
    Company:
    Biokin Pharma
    Drug class:
    Topoisomerase I inhibitor, HER2-targeted antibody-drug conjugate
    Related drugs:
    Apply
    A Study of BL-M07D1 in Patients With HER2-mutated, Locally Advanced or Metastatic Non-small-cell Lung Cancer (NCT06114511)
    Phase 1/2
    Sichuan Baili Pharmaceutical Co., Ltd.
    Recruiting
    Last update posted :
    05/14/2024
    Initiation :
    04/24/2024
    Primary completion :
    04/01/2026
    Completion :
    04/01/2026
    HER-2
    |
    HER-2 mutation
    |
    BL-M07D1
    A Study of BL-M07D1 in Patients With a Variety of Solid Tumors Including Locally Advanced or Metastatic HER2-positive/Low-expressing Urinary and Gastrointestinal Tumors (NCT06031584)
    Phase 1/2
    Sichuan Baili Pharmaceutical Co., Ltd.
    Recruiting
    Last update posted :
    03/08/2024
    Initiation :
    01/19/2024
    Primary completion :
    03/01/2026
    Completion :
    03/01/2026
    HER-2
    |
    HER-2 positive • HER-2 expression • HER-2 underexpression
    |
    BL-M07D1
    Phase I Clinical Study of BL-M07D1 in Locally Advanced or Metastatic Digestive Tract Tumors and Other Solid Tumors (NCT05631964)
    Phase 1
    Sichuan Baili Pharmaceutical Co., Ltd.
    Recruiting
    Last update posted :
    01/31/2024
    Initiation :
    01/05/2023
    Primary completion :
    01/01/2025
    Completion :
    01/01/2025
    HER-2
    |
    HER-2 positive • HER-2 amplification • HER-2 expression
    |
    BL-M07D1
    A Study of BL-M07D1 in Patients With Locally Advanced or Metastatic HER2 Positive/Low Expression Breast Cancer and Other Solid Tumors (NCT05461768)
    Phase 1
    Sichuan Baili Pharmaceutical Co., Ltd.
    Recruiting
    Last update posted :
    01/31/2024
    Initiation :
    08/09/2022
    Primary completion :
    08/01/2024
    Completion :
    08/01/2024
    HER-2
    |
    HER-2 positive • HER-2 expression • HER-2 underexpression
    |
    BL-M07D1